These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31395814)

  • 1. Fusion of Lysostaphin to an Albumin Binding Domain Prolongs Its Half-Life and Bactericidal Activity in the Systemic Circulation.
    Grishin AV; Shestak NV; Lavrova NV; Lyashchuk AM; Popova LI; Strukova NV; Generalova MS; Ryazanova AV; Polyakov NB; Galushkina ZM; Soboleva LA; Boksha IS; Karyagina AS; Lunin VG
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31395814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Influence of Dimerization on the Pharmacokinetics and Activity of an Antibacterial Enzyme Lysostaphin.
    Grishin AV; Lavrova NV; Lyashchuk AM; Strukova NV; Generalova MS; Ryazanova AV; Shestak NV; Boksha IS; Polyakov NB; Galushkina ZM; Soboleva LA; Vetchinin SS; Pavlov VM; Karyagina AS; Lunin VG
    Molecules; 2019 May; 24(10):. PubMed ID: 31100806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric phage lysins act synergistically with lysostaphin to kill mastitis-causing Staphylococcus aureus in murine mammary glands.
    Schmelcher M; Powell AM; Becker SC; Camp MJ; Donovan DM
    Appl Environ Microbiol; 2012 Apr; 78(7):2297-305. PubMed ID: 22286996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial and antibiofilm surfaces through polydopamine-assisted immobilization of lysostaphin as an antibacterial enzyme.
    Yeroslavsky G; Girshevitz O; Foster-Frey J; Donovan DM; Rahimipour S
    Langmuir; 2015 Jan; 31(3):1064-73. PubMed ID: 25547537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion with a cell wall binding domain renders autolysin LytM a potent anti-Staphylococcus aureus agent.
    Osipovitch DC; Griswold KE
    FEMS Microbiol Lett; 2015 Jan; 362(2):1-7. PubMed ID: 25670705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LytM Fusion with SH3b-Like Domain Expands Its Activity to Physiological Conditions.
    Jagielska E; Chojnacka O; Sabała I
    Microb Drug Resist; 2016 Sep; 22(6):461-9. PubMed ID: 27351490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antistaphylococcal activity of bacteriophage derived chimeric protein P128.
    Vipra AA; Desai SN; Roy P; Patil R; Raj JM; Narasimhaswamy N; Paul VD; Chikkamadaiah R; Sriram B
    BMC Microbiol; 2012 Mar; 12():41. PubMed ID: 22439788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved pharmacokinetics and reduced antibody reactivity of lysostaphin conjugated to polyethylene glycol.
    Walsh S; Shah A; Mond J
    Antimicrob Agents Chemother; 2003 Feb; 47(2):554-8. PubMed ID: 12543658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from hospitals in Beijing, China.
    Yang XY; Li CR; Lou RH; Wang YM; Zhang WX; Chen HZ; Huang QS; Han YX; Jiang JD; You XF
    J Med Microbiol; 2007 Jan; 56(Pt 1):71-76. PubMed ID: 17172520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiseptic effect of compound lysostaphin disinfectant and its preventive effect on infection of artificial dermis after graft on full-thickness skin defect wound in rats].
    Jin J; Zhou H; Cui ZC; Wang L; Luo PF; Ji SZ; Hu XY; Ma B; Wang GY; Zhu SH; Xia ZF
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):225-232. PubMed ID: 29690741
    [No Abstract]   [Full Text] [Related]  

  • 11. Lysostaphin: use of a recombinant bactericidal enzyme as a mastitis therapeutic.
    Oldham ER; Daley MJ
    J Dairy Sci; 1991 Dec; 74(12):4175-82. PubMed ID: 1787188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albumin-binding domain from Streptococcus zooepidemicus protein Zag as a novel strategy to improve the half-life of therapeutic proteins.
    Cantante C; Lourenço S; Morais M; Leandro J; Gano L; Silva N; Leandro P; Serrano M; Henriques AO; Andre A; Cunha-Santos C; Fontes C; Correia JDG; Aires-da-Silva F; Goncalves J
    J Biotechnol; 2017 Jul; 253():23-33. PubMed ID: 28549690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic Anti-Staphylococcal Activity Of Niosomal Recombinant Lysostaphin-LL-37.
    Sadeghi S; Bakhshandeh H; Ahangari Cohan R; Peirovi A; Ehsani P; Norouzian D
    Int J Nanomedicine; 2019; 14():9777-9792. PubMed ID: 31849468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA.
    Becker SC; Foster-Frey J; Donovan DM
    FEMS Microbiol Lett; 2008 Oct; 287(2):185-91. PubMed ID: 18721148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Chimeric LysK-Lysostaphin Fusion Enzyme Lysing Staphylococcus aureus Cells: a Study of Both Kinetics of Inactivation and Specifics of Interaction with Anionic Polymers.
    Filatova LY; Donovan DM; Ishnazarova NT; Foster-Frey JA; Becker SC; Pugachev VG; Balabushevich NG; Dmitrieva NF; Klyachko NL
    Appl Biochem Biotechnol; 2016 Oct; 180(3):544-557. PubMed ID: 27168405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysostaphin Lysibody Leads to Effective Opsonization and Killing of Methicillin-Resistant Staphylococcus aureus in a Murine Model.
    Raz A; Serrano A; Thaker M; Alston T; Fischetti VA
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30038041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid Antibacterial Activity Assessment of Chimeric Lysins.
    Park JM; Kim JH; Kim G; Sim HJ; Ahn SM; Choi KS; Kwon HJ
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of recombinant lysostaphin-antibiotic combinations toward methicillin-resistant Staphylococcus aureus.
    Polak J; Della Latta P; Blackburn P
    Diagn Microbiol Infect Dis; 1993; 17(4):265-70. PubMed ID: 8112040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrostatic-Mediated Affinity Tuning of Lysostaphin Accelerates Bacterial Lysis Kinetics and Enhances
    Zhao H; Eszterhas S; Furlon J; Cheng H; Griswold KE
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering of Long-Circulating Peptidoglycan Hydrolases Enables Efficient Treatment of Systemic Staphylococcus aureus Infection.
    Sobieraj AM; Huemer M; Zinsli LV; Meile S; Keller AP; Röhrig C; Eichenseher F; Shen Y; Zinkernagel AS; Loessner MJ; Schmelcher M
    mBio; 2020 Sep; 11(5):. PubMed ID: 32963004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.